从天然产品中发现和开发新药:进展和战略
Yixin Wang1, Fan Wang1, Wenxiu Liu1
1Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100193, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China.
Pharmacology & therapeutics
|November 18, 2024
概括
自然产品 (NPs) 对药物发现至关重要,为复杂疾病提供优势. 本综述探讨了NP药物开发,查和技术整合,以实现未来的治疗创新.
科学领域:
- 药理学和天然产品化学化学
- 药物发现和开发 药物发现和开发
- 药用化学 医学化学
背景情况:
- 自然产品 (NPs) 是药物发现的基石,超过一半的批准药物来源于自然产品,并对复杂疾病具有显著的临床益处.
- 尽管它们很重要,但由于复杂的作用机制和技术限制,NP生物活性选,目标识别和优化仍然存在挑战.
研究的目的:
- 提供天然产品药物开发策略的全面概述,包括生物活性和基于目标的方法.
- 系统地审查NP选,衍生,目标识别和验证方法方面的进展.
- 讨论传统和新兴技术的整合,并提出合作策略,以克服NP药物发现和开发中的挑战.
主要方法:
- 对自然产品药物发现模式的现有文献的审查.
- 对天然产品的生物活性查和目标识别方法的分析.
- 检查传统和新兴技术应用于天然产品研究.
- 讨论多技术整合和多学科方法.
主要成果:
- 自然产品在治疗复杂疾病方面提供了多方面的优势,许多已批准的药物都是从中衍生出来的.
- 在对天然产品的选,衍生和目标识别方面取得了重大进展.
- 传统技术和新兴技术都起着至关重要的作用,整合提供了协同效益.
- 在识别,优化,评估和临床应用方面的挑战需要合作战略.
结论:
- 自然产品仍然是新药发现的关键资源,提供独特的治疗潜力.
- 整合多样化的技术和跨学科的合作对于克服当前开发基于天然产品的治疗方法所面临的挑战至关重要.
- 未来的药物发现工作应该集中在对自然资源的系统探索和先进的技术整合上.
更多相关视频
相关概念视频
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Structure-Activity Relationships and Drug Design
597
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
597
Drug Administration and Therapy Phases: Overview
409
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
409
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K


